Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Abraxis BioScience LLC, part of Bristol Myers Squibb Co., is a company headquartered in Los Angeles, CA, involved in commercial physical and biological research.

Mercator MedSystems’ mission is to become a global leader in interventional, site-specific delivery of therapeutics that improve patient outcomes in vascular disease, oncology, and regenerative medicine. The 15th and 16th Centuries marked the beginning of the Age of Exploration, a time of bold action, vast territorial expansion and profound intellectual discovery. Gerardus Mercator (1512-1594), a mathematician and cartographer, played a key role in these ventures. He was as important to navigation as Copernicus was to astronomy. He perfected a map projection that was the first to represent the spherical surface of the earth in two dimensions. The Mercator Projection effectively transformed navigation, making it possible for ships to deliver cargo safely to any port on the globe. Inspired by the spirit of our namesake, Mercator MedSystems has developed a medical technology that enables the safe and accurate delivery of therapies anywhere in the body, ranging from drugs for diseased blood vessels, to stem cells that regenerate ailing tissues and organs. We believe this breakthrough will allow the expansion of medical therapy and stimulate profound intellectual exploration into new treatments for disease. We invite you to explore our web site, our technology and products, and to follow our progress to a new world of therapeutic delivery.

Gmax Biopharm LLC is a Chinese company located in Hangzhou that operates as an antibody development platform. It was founded by Shuqian Jing and Richard Xu. Shuqian Jing is currently the CEO of the firm.\nThe company says this about itself: Gmax is a clinical stage company established in 2010 and headquartered in Hangzhou, China. It's a global company focusing on R&D, production and commercialization of antibody drugs targeting GPCRs. Gmax mainly works in cardiovascular, metabolic and cancer areas. Currently there are four drug development programs in different stages of clinical trials: GMA 102 (type 2 diabetes), GMA105 (obesity), GMA301A (PAH for adult), and GMA 301B (PAH for children).

Moerae Matrix is a privately held biopharmaceutical company focused on the development of first-in-class targeted therapeutics for fibrotic diseases.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces; BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction; and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi-Arabia. The company was founded in 2001 and is based in Turku, Finland.

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Suzhou Esote Biotechnology Co., Ltd., established on 2011-01-20, Business scope includes bioengineering,Technology development in the field of biomedicine,technology transfer,Technical Services;Sales:biological reagent,biomaterial equipment,Chemical raw materials,cosmetic,electronic product,Computers and Accessories,Daily necessities,Office Supplies,crafts.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tribos LLC develops recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age, and inflammation-related conditions. The company was founded by Edward R. Truitt, Harry Barnett, Edmund R. Pitcher and Benjamin D. Sullivan and is headquartered in Framingham, MA.

Beijing Tianzhu Changyun Medical Technology Co., Ltd., established on 2002-11-13, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Since 1955, WAKUNAGA’s mission statement is “they serve the public’s health from the entrepreneur spirit and contribute to the society through the development of outstanding products by using the unique technology” . WAKUNAGA has been moving forward in developing reliable healthcare products to maintain your health.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.